Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5534-02-1
2. Betamethasone-17-butyrate-21-propionate
3. 50fh5ag9rw
4. [(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Butanoate
5. Betamethasone Butyrate Propionate [jan]
6. Antebate (tn)
7. Betamethasone Butyrate Propionate (jan)
8. Ncgc00183597-01
9. Dsstox_cid_2671
10. Unii-50fh5ag9rw
11. Dsstox_rid_76682
12. Dsstox_gsid_22671
13. Schembl120208
14. Betamethasone-butyrate-propionate
15. Chembl1697785
16. Dtxsid7022671
17. Niosh/tu3838700
18. Chebi:135815
19. Hy-b0775
20. Zinc3920457
21. Tox21_113030
22. Betamethasonebutyratepropionate
23. Cs-7180
24. Cas-5534-02-1
25. Tu38387000
26. Betamethasone Butyrate Propionate [mi]
27. D02032
28. Betamethasone 17-alpha-n-butyrate 21-propionate
29. Betamethasone Butyrate Propionate [who-dd]
30. Q27260787
31. (+)-9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-butyrate 21-propionate
32. (+)-9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-butyrate 21-propionate
33. (11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxo-21-(propanoyloxy)pregna-1,4-dien-17-yl Butanoate
34. 9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-
35. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11-beta,16-beta,17-alpha)-
36. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11beta,16beta)-
37. Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 17-butyrate 21-propionate
| Molecular Weight | 518.6 g/mol |
|---|---|
| Molecular Formula | C29H39FO7 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 518.26798174 g/mol |
| Monoisotopic Mass | 518.26798174 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1060 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Betamethasone Butyrate Propionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betamethasone Butyrate Propionate, including repackagers and relabelers. The FDA regulates Betamethasone Butyrate Propionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betamethasone Butyrate Propionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betamethasone Butyrate Propionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Betamethasone Butyrate Propionate supplier is an individual or a company that provides Betamethasone Butyrate Propionate active pharmaceutical ingredient (API) or Betamethasone Butyrate Propionate finished formulations upon request. The Betamethasone Butyrate Propionate suppliers may include Betamethasone Butyrate Propionate API manufacturers, exporters, distributors and traders.
click here to find a list of Betamethasone Butyrate Propionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Betamethasone Butyrate Propionate Drug Master File in Japan (Betamethasone Butyrate Propionate JDMF) empowers Betamethasone Butyrate Propionate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Betamethasone Butyrate Propionate JDMF during the approval evaluation for pharmaceutical products. At the time of Betamethasone Butyrate Propionate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Betamethasone Butyrate Propionate suppliers with JDMF on PharmaCompass.
Betamethasone Butyrate Propionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betamethasone Butyrate Propionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betamethasone Butyrate Propionate GMP manufacturer or Betamethasone Butyrate Propionate GMP API supplier for your needs.
A Betamethasone Butyrate Propionate CoA (Certificate of Analysis) is a formal document that attests to Betamethasone Butyrate Propionate's compliance with Betamethasone Butyrate Propionate specifications and serves as a tool for batch-level quality control.
Betamethasone Butyrate Propionate CoA mostly includes findings from lab analyses of a specific batch. For each Betamethasone Butyrate Propionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betamethasone Butyrate Propionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Betamethasone Butyrate Propionate EP), Betamethasone Butyrate Propionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betamethasone Butyrate Propionate USP).
LOOKING FOR A SUPPLIER?
